Skip to main content

and
  1. Article

    Open Access

    AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas

    Isocitrate dehydrogenase (IDH) mutations are disease-defining mutations in IDH-mutant astrocytomas and IDH-mutant and 1p/19q-codeleted oligodendrogliomas. In more than 80% of these tumors, point mutations in I...

    Lukas Bunse, Anne-Kathleen Rupp, Isabel Poschke in Neurological Research and Practice (2022)

  2. Article

    Open Access

    Clinical implementation of a 3D4K-exoscope (Orbeye) in microneurosurgery

    Exoscopic surgery promises alleviation of physical strain, improved intraoperative visualization and facilitation of the clinical workflow. In this prospective observational study, we investigate the clinical ...

    Judith Rösler, Stefan Georgiev, Anna L. Roethe, Denny Chakkalakal in Neurosurgical Review (2022)

  3. Article

    Open Access

    Augmented reality visualization in brain lesions: a prospective randomized controlled evaluation of its potential and current limitations in navigated microneurosurgery

    Augmented reality (AR) has the potential to support complex neurosurgical interventions by including visual information seamlessly. This study examines intraoperative visualization parameters and clinical impa...

    Anna L. Roethe, Judith Rösler, Martin Misch, Peter Vajkoczy in Acta Neurochirurgica (2022)

  4. Article

    Open Access

    Monitor-based exoscopic 3D4k neurosurgical interventions: a two-phase prospective-randomized clinical evaluation of a novel hybrid device

    Promoting a disruptive innovation in microsurgery, exoscopes promise alleviation of physical strain and improved image quality through digital visualization during microneurosurgical interventions. This study ...

    Anna L. Roethe, Philipp Landgraf, Torsten Schröder, Martin Misch in Acta Neurochirurgica (2020)

  5. Article

    Open Access

    T2 map** of molecular subtypes of WHO grade II/III gliomas

    According to the new WHO classification from 2016, molecular profiles have shown to provide reliable information about prognosis and treatment response. The purpose of our study is to evaluate the diagnostic p...

    Maike Kern, Timo Alexander Auer, Thomas Picht, Martin Misch, Edzard Wiener in BMC Neurology (2020)

  6. No Access

    Article

    18F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors

    MRI alone has its limitations for target selection in biopsy or resection in newly diagnosed and pretreated pediatric brain tumor patients. 18F-FET-PET imaging is considered to identify metabolically active tumor...

    Martin Misch, Andreas Guggemos, Pablo Hernáiz Driever, Arend Koch in Child's Nervous System (2015)

  7. No Access

    Article

    Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas

    Malignant gliomas are highly infiltrative tumours with a fatal prognosis. F18-fluoroethyl-tyrosine (FET)-positron emission tomography (PET) often reveals a broader extension of these tumours compared with cont...

    Florian Stockhammer, Martin Misch, Peter Horn, Arend Koch in Acta Neurochirurgica (2009)